Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Feiteng Lu"'
Autor:
Jiaxin Cao, Kangmei Zeng, Qun Chen, Ting Yang, Feiteng Lu, Chaozhuo Lin, Jianhua Zhan, Wenjuan Ma, Ting Zhou, Yan Huang, Fan Luo, Hongyun Zhao
Publikováno v:
Cell Death and Disease, Vol 15, Iss 3, Pp 1-15 (2024)
Abstract End-stage nasopharyngeal carcinoma (NPC) has unsatisfactory survival. The limited benefit of chemotherapy and the scarcity of targeted drugs are major challenges in NPC. New approaches to treat late-stage NPC are urgently required. In this s
Externí odkaz:
https://doaj.org/article/199c969377334b599c78050b84ac1bbd
Autor:
Zhonghan Zhang, Jinhui Xue, Yunpeng Yang, Wenfeng Fang, Yan Huang, Shen Zhao, Fan Luo, Jiaxin Cao, Kangmei Zeng, Wenjuan Ma, Jianhua Zhan, Feiteng Lu, Li Zhang, Hongyun Zhao
Publikováno v:
MedComm, Vol 5, Iss 6, Pp n/a-n/a (2024)
Abstract TP53 comutation is related to poor prognosis of non‐small cell lung cancer. However, there is limited study focusing on the structural influence of TP53 mutation on third‐generation epidermal growth factor receptor tyrosine kinase inhibi
Externí odkaz:
https://doaj.org/article/efaaf10675ae4c75be284d3463f942ca
Autor:
Jiaxin Cao, Qun Chen, Xue Bai, Lusha Liu, Wenjuan Ma, Chaozhuo Lin, Feiteng Lu, Ting Zhou, Jianhua Zhan, Yan Huang, Yunpeng Yang, Fan Luo, Hongyun Zhao
Publikováno v:
Annals of Medicine, Vol 55, Iss 2 (2023)
AbstractBackground Immune checkpoint inhibitors (ICIs) have achieved substantial advancements in clinical care. However, there is no strong evidence for identified biomarkers of ICIs in NPC.Methods In this retrospective study, 284 patients were enrol
Externí odkaz:
https://doaj.org/article/d64cb67eeade4e5d86e7032311ac1d89
Autor:
Zhonghan Zhang, Fan Luo, Jiaxin Cao, Feiteng Lu, Yang Zhang, Yuxiang Ma, Kangmei Zeng, Li Zhang, Hongyun Zhao
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-5 (2021)
Abstract Background The bispecific antibody (bsAbs) research around the world has undergone great changes. We analyzed the global trend of bsAbs research and compared the differences in clinical research of bsAbs between China and worldwide. Methods
Externí odkaz:
https://doaj.org/article/c9e098dc498c46359133868ace0ff0ab
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-16 (2021)
Abstract Background Immunotherapy has shown promising efficacy in patients with nasopharyngeal carcinoma (NPC). Lymphocyte activating 3 gene (LAG-3) represents a significant immune target, however, its relationship with NPC remains unclear. This stud
Externí odkaz:
https://doaj.org/article/084c41865c5f4730ab0448cbb5d490c6
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background The clinical and experimental evidences for complement-cancer relationships are solid, whereas an epidemiological study reporting the imbalance of complement system in patients is still lacking. Methods Using publicly available da
Externí odkaz:
https://doaj.org/article/2c649e27e85846e8bf2162d507a55b5b
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/97de27814bc24df1b9125a416dd031c7
Autor:
Zhonghan Zhang, Kangmei Zeng, Shen Zhao, Yuanyuan Zhao, Xue Hou, Fan Luo, Feiteng Lu, Yaxiong Zhang, Ting Zhou, Yuxiang Ma, Yunpeng Yang, Wenfeng Fang, Yan Huang, Li Zhang, Hongyun Zhao
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Background: First-line treatments for nonsmall cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations have been evaluated in various clinical trials. However, it remains unclear which is the optimal treatment. Methods: A
Externí odkaz:
https://doaj.org/article/2bb31cbace41495eabadfc061cc48030
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-2 (2019)
Following publication of the original article [1], it was noticed that Fig. 3c was omitted from the final published article.
Externí odkaz:
https://doaj.org/article/546b8757426242f29c286cdba9c30c69
Autor:
Ting Zhou, Kangmei Zeng, Li Zhang, Zhonghan Zhang, Hongyun Zhao, Jia-Xin Cao, Wen-Juan Ma, Fan Luo, Yunpeng Yang, Feiteng Lu, Yan Huang, Su-Xia Lin
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-14 (2021)
Lipids in Health and Disease
Lipids in Health and Disease
Background Cancer patients often exhibit chemotherapy-associated changes in serum lipid profiles, however, their prognostic value before and after adjuvant chemotherapy on survival among non-small-cell lung cancer (NSCLC) patients is unknown. Methods